0001177648-19-000020.txt : 20190301
0001177648-19-000020.hdr.sgml : 20190301
20190301200355
ACCESSION NUMBER: 0001177648-19-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190301
DATE AS OF CHANGE: 20190301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARTER BRUCE L A
CENTRAL INDEX KEY: 0001225503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35839
FILM NUMBER: 19651479
MAIL ADDRESS:
STREET 1: C/O ZYMOGENETICS, INC.
STREET 2: 1201 EASTLAKE AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001177648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617 607 0800
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-02-28
0001177648
ENANTA PHARMACEUTICALS INC
ENTA
0001225503
CARTER BRUCE L A
C/O ENANTA PHARMACEUTICALS, INC.
500 ARSENAL STREET
WATERTOWN
MA
02472
1
0
0
0
Stock Option (right to buy)
102.54
2019-02-28
4
A
0
5000
0
A
2029-02-28
Common Stock
5000
5000
D
Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 28, 2019), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2020 annual meeting of stockholders.
/s/ Nathaniel S. Gardiner as attorney-in-fact
2019-03-01